-Bloomberg
Related Posts
OptimizeRx Q2 EPS $0.10 Beats $0.07 Estimate, Sales $13.60M Beat $12.45M Estimate
OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. This is a 400 percent increase over earnings of $0.02 per share from the same
Investor Fear Increases Further As Dow Enters Bear Market
The CNN Money Fear and Greed index shower further rise in the fear level after Wall Street closed lower on Monday.
The Dow Jones fell into a bear market on Monday, while the S&P 500 recorded a fresh closing low level for the year.
UBS Initiates Coverage On Reynolds Consumer with Neutral Rating, Announces Price Target of $32
UBS initiates coverage on Reynolds Consumer (NASDAQ:REYN) with a Neutral rating and announces Price Target of $32.